Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients.
Journal article
Colton H. et al, (2024), Br J Haematol
COVID-19 vaccines are effective at preventing symptomatic and severe infection among healthcare workers: A clinical review
Journal article
Galgut O. et al, (2024), Vaccine: X, 20
Starvation and infection: The role of sickness-associated anorexia in metabolic adaptation during acute infection.
Journal article
Jindal J. et al, (2024), Metabolism
Dysregulated immunologic landscape of the early host response in melioidosis.
Journal article
Rongkard P. et al, (2024), JCI Insight, 9
Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.
Journal article
Duyvesteyn HME. et al, (2024), Structure
Using matrix assisted laser desorption ionisation mass spectrometry combined with machine learning for vaccine authenticity screening
Journal article
Clarke R. et al, (2024), npj Vaccines
Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
Journal article
Suwarti S. et al, (2024), BMC Infect Dis, 24
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: a prospective observational study in Vietnam.
Journal article
Thanh TT. et al, (2024), Int J Infect Dis
Implications of suboptimal measles immunity in UK health-care workers.
Journal article
Ho A. et al, (2024), Lancet, 404, 23 - 24
Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy.
Journal article
Lim YJ. et al, (2024), Br J Haematol
Diabetes and risk of hospitalisation due to infection in northeastern Thailand: Retrospective cohort study using population-based healthcare service data.
Journal article
Peerawaranun P. et al, (2024), Diabet Med
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
Journal article
GBD 2021 Demographics Collaborators None., (2024), Lancet, 403, 1989 - 2056
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.
Journal article
Goodyear CS. et al, (2024), Lancet Rheumatol
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity.
Journal article
Liu C. et al, (2024), Cell Rep Med
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study.
Journal article
Jackson S. et al, (2024), Lancet Microbe
Obesity Differs from Diabetes Mellitus in Antibody and T Cell Responses Post COVID-19 Recovery.
Journal article
Ali M. et al, (2024), Clin Exp Immunol
Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
Journal article
IHME Pathogen Core Group None., (2024), Lancet Infect Dis
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.
Journal article
Zhou D. et al, (2024), Nat Commun, 15
Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990-2019: a modelling study.
Journal article
GRAM Typhoid Collaborators None., (2024), Lancet Glob Health, 12, e406 - e418